Overview

NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment

Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
This study will provide insight into whether a nutritional supplement, nicotinamide riboside (NR), improves memory and brain blood flow in older adults with low memory abilities. Overall, this project has the potential to identify a novel, safe and cost-effective strategy for decreasing age-related memory loss.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Delaware
Collaborator:
National Institute on Aging (NIA)
Treatments:
Niacin
Niacinamide
Nicotinic Acids